These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
447 related items for PubMed ID: 22971207
1. Additive effect of tadalafil and simvastatin on monocrotaline-induced pulmonary hypertension rats. Zhang WH, Liu CP, Zhang YJ, Ji YQ, Lu WX, Zeng Q. Scand Cardiovasc J; 2012 Dec; 46(6):374-80. PubMed ID: 22971207 [Abstract] [Full Text] [Related]
2. Attenuation of monocrotaline-induced pulmonary arterial hypertension in rats by rosuvastatin. Li XL, Guan RJ, Li JJ. J Cardiovasc Pharmacol; 2012 Aug; 60(2):219-26. PubMed ID: 22592772 [Abstract] [Full Text] [Related]
3. Rosuvastatin, sildenafil and their combination in monocrotaline-induced pulmonary hypertension in rat. Jasińska-Stroschein M, Owczarek J, Wesołowska A, Orszulak-Michalak D. Acta Pharm; 2014 Sep; 64(3):345-53. PubMed ID: 25296680 [Abstract] [Full Text] [Related]
4. Combined effects of the ATP-sensitive potassium channel opener pinacidil and simvastatin on pulmonary vascular remodeling in rats with monocrotaline-induced pulmonary arterial hypertension. Jiang L, Zhou T, Liu H. Pharmazie; 2012 Jun; 67(6):547-52. PubMed ID: 22822545 [Abstract] [Full Text] [Related]
5. Simvastatin attenuates smooth muscle neointimal proliferation and pulmonary hypertension in rats. Nishimura T, Faul JL, Berry GJ, Vaszar LT, Qiu D, Pearl RG, Kao PN. Am J Respir Crit Care Med; 2002 Nov 15; 166(10):1403-8. PubMed ID: 12406854 [Abstract] [Full Text] [Related]
6. Antiremodeling effects of iloprost and the dual-selective phosphodiesterase 3/4 inhibitor tolafentrine in chronic experimental pulmonary hypertension. Schermuly RT, Kreisselmeier KP, Ghofrani HA, Samidurai A, Pullamsetti S, Weissmann N, Schudt C, Ermert L, Seeger W, Grimminger F. Circ Res; 2004 Apr 30; 94(8):1101-8. PubMed ID: 15031263 [Abstract] [Full Text] [Related]
7. Simvastatin protects against the development of monocrotaline-induced pulmonary hypertension in rats via a heme oxygenase-1-dependent pathway. Zhang WH, Zhang YJ, Liu CP, Yu BX, Lu WX. Exp Lung Res; 2011 Oct 30; 37(8):492-9. PubMed ID: 21867382 [Abstract] [Full Text] [Related]
8. Sildenafil preserves lung endothelial function and prevents pulmonary vascular remodeling in a rat model of diastolic heart failure. Yin J, Kukucka M, Hoffmann J, Sterner-Kock A, Burhenne J, Haefeli WE, Kuppe H, Kuebler WM. Circ Heart Fail; 2011 Mar 30; 4(2):198-206. PubMed ID: 21216837 [Abstract] [Full Text] [Related]
9. 3-Hydroxy-3-methylglutaryl (HMG)-COA reductase inhibitors and phosphodiesterase type V inhibitors attenuate right ventricular pressure and remodeling in a rat model of pulmonary hypertension. Satoh M, Satoh A. J Pharm Pharm Sci; 2009 Feb 04; 11(2):118s-130s. PubMed ID: 19203474 [Abstract] [Full Text] [Related]
10. The extracellular signal-regulated kinase is involved in the effects of sildenafil on pulmonary vascular remodeling. Zeng Z, Li Y, Jiang Z, Wang C, Li B, Jiang W. Cardiovasc Ther; 2010 Feb 04; 28(1):23-9. PubMed ID: 20074256 [Abstract] [Full Text] [Related]
11. Oral sildenafil prevents and reverses the development of pulmonary hypertension in monocrotaline-treated rats. Liu H, Liu ZY, Guan Q. Interact Cardiovasc Thorac Surg; 2007 Oct 04; 6(5):608-13. PubMed ID: 17670742 [Abstract] [Full Text] [Related]
12. Glycyrrhizin, inhibitor of high mobility group box-1, attenuates monocrotaline-induced pulmonary hypertension and vascular remodeling in rats. Yang PS, Kim DH, Lee YJ, Lee SE, Kang WJ, Chang HJ, Shin JS. Respir Res; 2014 Nov 25; 15():148. PubMed ID: 25420924 [Abstract] [Full Text] [Related]
13. [Simvastatin prevents the development of pulmonary hypertension in the rats through reduction of inflammation]. Zhang WH, Lu WX, Zhang YJ, Ji YQ, Liu CP, Li G. Zhonghua Yi Xue Za Zhi; 2009 Mar 31; 89(12):855-9. PubMed ID: 19595129 [Abstract] [Full Text] [Related]
14. Chronic inhibition of phosphodiesterase 5 does not prevent pressure-overload-induced right-ventricular remodelling. Schäfer S, Ellinghaus P, Janssen W, Kramer F, Lustig K, Milting H, Kast R, Klein M. Cardiovasc Res; 2009 Apr 01; 82(1):30-9. PubMed ID: 19131365 [Abstract] [Full Text] [Related]
15. Effects of masitinib compared with tadalafil for the treatment of monocrotaline-induced pulmonary arterial hypertension in rats. Leong ZP, Hikasa Y. Vascul Pharmacol; 2019 Apr 01; 122-123():106599. PubMed ID: 31629919 [Abstract] [Full Text] [Related]
16. Effects of atorvastatin and losartan on monocrotaline-induced pulmonary artery remodeling in rats. Xie L, Lin P, Xie H, Xu C. Clin Exp Hypertens; 2010 Apr 01; 32(8):547-54. PubMed ID: 21091363 [Abstract] [Full Text] [Related]
17. [Effect of simvastatin on rat pulmonary hypertension induced by high pulmonary blood flow and injected monocrotaline]. Zhao L, Zhou TF, Liu HM, Li M, Dou H, Tang ZH. Sichuan Da Xue Xue Bao Yi Xue Ban; 2007 Jun 01; 38(3):463-5, 479. PubMed ID: 17593832 [Abstract] [Full Text] [Related]
18. Tetrandrine prevents monocrotaline-induced pulmonary arterial hypertension in rats through regulation of the protein expression of inducible nitric oxide synthase and cyclic guanosine monophosphate-dependent protein kinase type 1. Wang X, Yang Y, Yang D, Tong G, Lv S, Lin X, Chen C, Dong W. J Vasc Surg; 2016 Nov 01; 64(5):1468-1477. PubMed ID: 26527422 [Abstract] [Full Text] [Related]
19. Simvastatin restores down-regulated GATA-6 expression in pulmonary hypertensive rats. Liu B, Wang XQ, Yu L, Zhou TF, Wang XM, Liu HM. Exp Lung Res; 2009 Jun 01; 35(5):411-26. PubMed ID: 19842842 [Abstract] [Full Text] [Related]
20. [Protective effects of beraprost plus simvastatin on monocrotaline-induced pulmonary arterial hypertension in rats]. Wang SH, Liu S, Yang JH, Wang ZZ, Li J, Hou WW. Zhonghua Yi Xue Za Zhi; 2013 Jun 11; 93(22):1691-5. PubMed ID: 24124673 [Abstract] [Full Text] [Related] Page: [Next] [New Search]